Ángela Bernardo a fait une demande de Accès à l'information à Agence européenne des médicaments
This request has been closed to new correspondence. Contact us if you think it should be reopened.
Dear European Medicines Agency,
Under the right of access to documents in the EU treaties, as developed in Regulation 1049/2001, I am requesting documents which contain the following information:
- Correspondence (including emails and their attachments) involving officials/representatives from the European Medicines Agency and all the national competent authorities of the Member States of the European Union (EU) and the European Economic Area (EEA) responsible for human medicines which refer to the issue of Vaxzevria (formerly COVID-19 Vaccine AstraZeneca).
- Correspondence (including emails and their attachments) involving officials/representatives from the European Medicines Agency and all the national competent authorities of the Member States of the European Union (EU) and the European Economic Area (EEA) responsible for human medicines which refer to the issue of COVID-19 Vaccine Janssen.
- Data related to the cases of unusual blood clots with low blood platelets found after the administration of any of the authorised COVID-19 vaccines in the Member States of the European Union (EU) and the European Economic Area (EEA), including information regarding gender and age of the people affected by these unusual events.
Delivery has failed to these recipients or groups:
documents requests at EMA ([EMA request email])
The email address you entered couldn't be found. Please check the
recipient's email address and try to resend the message. If the problem
continues, please contact your helpdesk.
Diagnostic information for administrators:
Generating server: wv1278.emea.eu.int
[EMA request email]
Remote Server returned '550 5.1.1 RESOLVER.ADR.RecipNotFound; not found'
Original message headers:
Received: from wv1275.emea.eu.int (172.16.91.20) by wv1278.emea.eu.int
(172.16.91.23) with Microsoft SMTP Server (TLS) id 15.0.1497.2; Tue, 27 Apr
2021 19:59:34 +0200
Received: from mail6.bemta26.messagelabs.com (172.16.40.221) by
wv1275.emea.eu.int (172.16.91.20) with Microsoft SMTP Server (TLS) id
15.0.1497.2 via Frontend Transport; Tue, 27 Apr 2021 19:59:34 +0200
Return-Path: <[FOI #9389 email]>
Received: from [100.113.2.110] (using TLSv1.2 with cipher DHE-RSA-AES256-GCM-SHA384 (256 bits))
by server-3.bemta.az-a.eu-central-1.aws.symcld.net id 86/D1-41911-50158806; Tue, 27 Apr 2021 17:59:33 +0000
Authentication-Results: mx.messagelabs.com; spf=pass
(server-23.tower-225.messagelabs.com: domain of asktheeu.org designates
184.108.40.206 as permitted sender) smtp.mailfrom=asktheeu.org; dkim=none
(message not signed); dmarc=none (no record) header.from=asktheeu.org
X-Env-Sender: [FOI #9389 email]
X-SpamReason: No, hits=0.0 required=7.0 tests=newsletters:
X-StarScan-Version: 9.75.3; banners=-,-,-
Received: (qmail 20031 invoked from network); 27 Apr 2021 17:59:33 -0000
Received: from owl.ukcod.org.uk (HELO owl.ukcod.org.uk) (220.127.116.11)
by server-23.tower-225.messagelabs.com with ECDHE-RSA-AES256-GCM-SHA384 encrypted SMTP; 27 Apr 2021 17:59:33 -0000
Received: from foieu by owl.ukcod.org.uk with local (Exim 4.89)
(envelope-from <[FOI #9389 email]>)
for [EMA request email]; Tue, 27 Apr 2021 18:59:32 +0100
Date: Tue, 27 Apr 2021 18:59:32 +0100
<[FOI #9389 email]>
To: documents requests at EMA <[EMA request email]>
Message-ID: <[email address]>
Subject: access to documents request - COVID-19 vaccines
Content-Type: text/plain; charset="UTF-8"
1. mailto:[EMA request email]